|
PIK3CA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.73530000000022E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.679900E-02 |
| Normal-vs-Stage2 |
8.423900E-03 |
| Normal-vs-Stage3 |
1.61411999999306E-05 |
| Normal-vs-Stage4 |
1.15860000005075E-06 |
| Stage1-vs-Stage2 |
1.352750E-01 |
| Stage1-vs-Stage3 |
2.263100E-03 |
| Stage1-vs-Stage4 |
6.956800E-04 |
| Stage2-vs-Stage3 |
4.843800E-01 |
| Stage2-vs-Stage4 |
2.337200E-01 |
| Stage3-vs-Stage4 |
5.493000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.235200E-04 |
| Normal-vs-AfricanAmerican |
9.61480000000181E-05 |
| Normal-vs-Asian |
5.127400E-01 |
| Caucasian-vs-AfricanAmerican |
9.666400E-02 |
| Caucasian-vs-Asian |
6.159000E-01 |
| AfricanAmerican-vs-Asian |
2.401000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.134999999992E-05 |
| Normal-vs-Female |
8.040700E-03 |
| Male-vs-Female |
1.281980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.777700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.831670E-02 |
| Normal-vs-Age(61-80Yrs) |
3.96530000001949E-06 |
| Normal-vs-Age(81-100Yrs) |
3.58750000000185E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.862000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.674800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.882630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.113700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.272100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.457840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.037800E-01 |
| Normal-vs-Grade 2 |
3.374100E-02 |
| Normal-vs-Grade 3 |
2.02879999999794E-05 |
| Normal-vs-Grade 4 |
1.01669999974519E-07 |
| Grade 1-vs-Grade 2 |
1.423250E-01 |
| Grade 1-vs-Grade 3 |
1.600330E-02 |
| Grade 1-vs-Grade 4 |
7.810500E-04 |
| Grade 2-vs-Grade 3 |
1.247890E-02 |
| Grade 2-vs-Grade 4 |
2.580400E-04 |
| Grade 3-vs-Grade 4 |
5.810100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.543830E-01 |
| Normal-vs-ccB subtype |
1.580660E-03 |
| ccA subtype-vs-ccB subtype |
3.355900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.878750E-03 |
| Normal-vs-N1 |
3.295900E-02 |
| N0-vs-N1 |
2.472200E-01 |
|
|
